Skip to main content

Advertisement

Log in

Reversible Electrochemotherapy (ECT) as a Treatment Option for Local RCC Recurrence in Solitary Kidney

  • Case Report
  • Published:
CardioVascular and Interventional Radiology Aims and scope Submit manuscript

Abstract

A 61-year-old female underwent a right radical nephrectomy and a left nephron sparing surgery in 2014 due to renal cell carcinoma. A renal cell carcinoma local recurrence, 28 mm in size, centrally located in the left kidney was treated using cryoablation in 2016. In November 2018, computed tomography (CT) scan showed three nodules (maximum size 15 × 11 mm) in the left kidney, and CT-guided needle biopsy was performed. For multifocal recurrence and the anatomical site of these three nodules, a simultaneous reversible electrochemotherapy treatment was performed in April 2019. At 6-month CT control, no evidence of residual disease was found. Electrochemotherapy could be used to treat locoregional renal cell carcinoma recurrence when other ablative techniques are not suitable.

Level of Evidence

Level 4, Case Report.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

REFERENCES

  1. Probst U, Fuhrmann I, Beyer L, Wiggermann P. Electrochemotherapy as a new modality in interventional oncology: a review. Technol Cancer Res Treat. 2018;1(17):1533033818785329.

    Google Scholar 

  2. Weaver JC, Chizmadzhev YA. Theory of electroporation: a review. Bioelectrochem Bioenerg. 1996;41:135–60.

    Article  CAS  Google Scholar 

  3. Marty M, Sersa G, Garbay JR, Gehl J, Collins CG, Snoj M, Billard V, Geertsen PF, Larkin JO, Miklavcic D, Pavlovic I, Paulin-Kosir SM, Cemazar M, Morsli N, Soden DM, Rudolf Z, Robert C, O’Sullivan GC, Mira LM. Electrochemotherapy—an easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study. EJC Suppl. 2006;4(11):3–13.

    Article  CAS  Google Scholar 

  4. Quaglino P, Mortera C, Osella-Abate S, Barberis M, Illengo M, Rissone M, Savoia P, Bernengo MG. Electrochemotherapy with intravenous bleomycin in the local treatment of skin melanoma metastases. Ann Surg Oncol. 2008;15(8):2215–22.

    Article  CAS  Google Scholar 

  5. Gasljevic G, Edhemovic I, Cemazar M, Brecelj E, Gadzijev EM, Music MM, Sersa G. Histopathological findings in colorectal liver metastases after electrochemotherapy. PLoS ONE. 2017;12(7):e0180709.

    Article  Google Scholar 

  6. Chazal M, Benchimol D, Baqué P, Pierrefite V, Milano G, Bourgeon A. Treatment of hepatic metastases of colorectal cancer by electrochemotherapy: an experimental study in the rat. Surgery. 1998;124(3):536–40.

    Article  CAS  Google Scholar 

  7. Pliquett U, Langer R, Weaver J. Changes in the passive electrical properties of human stratum corneum due to electroporation. Biochim Biophys Acta. 1995;1239(2):111–21.

    Article  CAS  Google Scholar 

  8. Perrone AM, Cima S, Pozzati F, Frakulli R, Cammelli S, Tesei M, Gasparre G, Galuppi A, Morganti AG, De Iaco P. Palliative electrochemotherapy in elderly patients with vulvar cancer: a phase II trial. J Surg Oncol. 2015;112(5):529–32.

    Article  Google Scholar 

  9. Okino M, Mohri H. Effects of a high-voltage electrical impulse and an anticancer drug on in vivo growing tumors. Jpn J Cancer Res. 1987;78(12):1319–21.

    CAS  PubMed  Google Scholar 

  10. Sersa G, Jarm T, Kotnik T, Coer A, Podkrajsek M, Sentjurc M, Miklavcic D, Kadivec M, Kranjc S, Secerov A, Cemazar M. Vascular disrupting action of electroporation and electrochemotherapy with bleomycin in murine sarcoma. Br J Cancer. 2008;98(2):388–98.

    Article  CAS  Google Scholar 

  11. Cornelis FH, Ben Ammar M, Nouri-Neuville M, Matton L, Benderra MA, Gligorov J, Fallet V, Mir LM. Percutaneous image-guided electrochemotherapy of spine metastases: initial experience. Cardiovasc Intervent Radiol. 2019;42(12):1806–9.

    Article  Google Scholar 

Download references

Funding

No funding sources.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R. F. Grasso.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interests.

Ethical Approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed Consent

Informed consent was obtained from all individual participants included in the study.

Consent for Publication

Consent for publication was obtained for every individual person’s data included in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Andresciani, F., Faiella, E., Altomare, C. et al. Reversible Electrochemotherapy (ECT) as a Treatment Option for Local RCC Recurrence in Solitary Kidney. Cardiovasc Intervent Radiol 43, 1091–1094 (2020). https://doi.org/10.1007/s00270-020-02498-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00270-020-02498-2

Keywords

Navigation